The Centers for Medicare & Medicaid Services (CMS) accepted a formal request to provide a national coverage analysis (NCA) for the Abbott TriClip. BTIG analysts Marie Thibault and Sam Eiber say Abbott requested the NCA for its transcatheter edge-to-edge repair system for treating tricuspid valve regurgitation (T-TEER). It falls under a pilot through the Transitional […]
Centers for Medicare and Medicaid Services (CMS)
Medtronic, Recor Medical earn CMS NTAP wins for renal denervation tech
Medtronic and Recor Medical earned a reimbursement win for their renal denervation (RDN) platforms with a new Final Rule from CMS. CMS posted its FY25 Inpatient Prospective Payment System (IPPS) Final Rule, which includes the New Technology Add-on Payment (NTAP) program. NTAP supports access for newly approved, innovative technologies where the cost to adopt may […]
CVRx earns Medicare win for Barostim procedure
CVRx (Nasdaq:CVRX) announced today that the Centers for Medicare and Medicaid Services (CMS) reassigned its Barostim implant procedure. CMS reassigned Barostim for the inpatient setting as part of the Fiscal Year (FY) 2025 Medicare Hospital Inpatient Prospective Payment System (IPPS) final rule. In FY 2024, CMS assigned Barostim to MS-DRGs 252, 253, 254. That had […]
Cala names new CEO, earns Medicare coverage for TAPS therapy
Cala announced today that it picked a new CEO as its TAPS therapy for essential tremor (ET) received Medicare coverage. The company promoted current Chief Product Officer Deanna Harshbarger to the corner office, effective immediately. She also becomes a member of the company’s board of directors. Renee Ryan, who became CEO at Cala in 2019, […]
Ekso Bionics earns Medicare win for exoskeleton tech
Ekso Bionics (Nasdaq:EKSO) announced that the Centers for Medicare & Medicaid Services (CMS) proposed a payment level for its exoskeleton. The Pricing, Data Analysis, and Coding (PDAC) contractor completed its review of the Ekso Indego Personal, approving the use of Healthcare Common Procedure Coding System (HCPCS) Code K1007 to bill Medicare for the device. CMS […]
CVRx scores Medicare win on outpatient Barostim payments
CVRx (Nasdaq:CVRX) announced today that the Centers for Medicare and Medicaid Services (CMS) reassigned its Barostim implant procedure. The CMS change assigns the CVRx neuromodulation implant for procedures performed in the outpatient setting. It comes as part of the 2024 Medicare Hospital Outpatient Prospective Payment System (OPPS) final rule. Barostim’s reassignment brings it to New Technology […]
ReWalk Robotics announces solidified Medicare coverage for personal exoskeleton
ReWalk Robotics (Nasdaq:RWLK) announced that the Centers for Medicare & Medicaid Services (CMS) finalized a rule benefitting its exoskeleton technology. Earlier this year, CMS released a proposal aiming to establish new regulatory definition of “brace.” Adding the definition of brace would expedite coverage and payment for newer technology and powered devices, according to CMS. This potentially […]
Cordis applauds Medicare expansion for carotid stenting
Cordis announced today that it supports a new expanded coverage decision from the Centers for Medicare & Medicaid Services (CMS). The expanded CMS coverage widens access to minimally invasive endovascular carotid therapy for patients with carotid artery disease. Cordis develops the Precise Pro Rx carotid stent system for this therapy. In a news release, the […]
Myomo prices $4.4M offering, scores reimbursement win
Myomo (NYSE:MYO) announced today that it priced a “reasonable best efforts” public offering worth proceeds of approximately $4.4 million. Boston-based Myomo’s offering includes more than 7.3 million shares of common stock priced at 60¢ per share. The company expects to close the offering on or about Aug. 29, 2023, subject to customary conditions. Myomo develops […]
Abbott FreeStyle Libre 3 reader is now available, covered by Medicare
Abbott has made its FreeStyle Libre 3 reader available in the U.S., enabling people on Medicare to access the system. The FreeStyle Libre 3 reader pairs with the company’s latest continuous glucose monitor (CGM) sensor, cleared by the FDA last year. The addressable market for the sensor keeps growing, with massive coverage expansions all around […]
Medicare now covers new Medtronic MiniMed 780G automated insulin pump
Medtronic (NYSE:MDT) announced today that Medicare now covers its new MiniMed 780G system with the Guardian 4 sensor. Coverage for the recently FDA-approved automated insulin delivery system extends to all eligible Medicare and Medicare Advantage beneficiaries. Medtronic intends to begin processing orders immediately. The company plans to start shipments to eligible recipients with type 1 […]
